Velnex Medicare India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.00 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.88 Cr
- Revenue Growth 16200.84%
- Profit Growth 2347.94%
- Ebitda 452.34%
- Net Worth 5.15%
- Total Assets 80.08%
About Velnex Medicare India
Velnex Medicare India Private Limited (VMIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 18 May 2020 (Four years and eight months 17 days old ). Its registered office is in Ambala, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.88 Cr.
Vikas Gupta and Chirag Singla serve as directors at the Company.
Company Details
-
Location
Ambala, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24230HR2020PTC086271
-
Company No.
086271
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
18 May 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Velnex Medicare India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vikas Gupta
|
Director | 18-May-2020 | Current |
|
Chirag Singla
|
Director | 13-Jan-2021 | Current |
Financial Performance of Velnex Medicare India.
Velnex Medicare India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 16200.84% increase. The company also saw a substantial improvement in profitability, with a 2347.94% increase in profit. The company's net worth moved up by a moderate rise of 5.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Velnex Medicare India?
In 2021, Velnex Medicare India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aspo Pharmaceuticals LlpVikas Gupta is a mutual person
Charges (Loans)
₹18.78 M
₹0
Charges Breakdown by Lending Institutions
- Others : 1.88 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Oct 2024 | Others | ₹1.90 M | Open |
| 28 Oct 2024 | Others | ₹1.88 M | Open |
| 17 Mar 2021 | Others | ₹1.50 Cr | Open |
How Many Employees Work at Velnex Medicare India?
Velnex Medicare India has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Velnex Medicare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Velnex Medicare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
